FATE THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fate Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q3 2024.
  • Fate Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$52.4M, a 2.14% decline year-over-year.
  • Fate Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$197M, a 4.96% increase year-over-year.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2023 was -$191M, a 38.2% increase from 2022.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2022 was -$308M, a 42.1% decline from 2021.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2021 was -$217M, a 69.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$197M -$52.4M -$1.1M -2.14% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$196M -$45.1M +$17.5M +27.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$213M -$51.1M -$22.5M -78.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$191M -$48.1M +$16.3M +25.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$207M -$51.3M +$35.1M +40.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$242M -$62.6M +$20.5M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$263M -$28.6M +$45.9M +61.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$308M -$64.4M +$4.96M +7.15% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$313M -$86.4M -$31.8M -58.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$282M -$83.1M -$36.3M -77.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$245M -$74.5M -$28.3M -61.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$217M -$69.4M -$36M -108% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$181M -$54.6M -$23.1M -73.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$158M -$46.8M -$18.1M -63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$140M -$46.2M -$11.7M -34% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$128M -$33.4M -$4.32M -14.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$124M -$31.5M -$4.37M -16.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$119M -$28.7M -$4.62M -19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$115M -$34.5M -$14M -68.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$101M -$29.1M -$12.3M -73.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$88.4M -$27.1M -$10.4M -62.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$78M -$24.1M -$4.48M -22.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$73.5M -$20.4M -$6.39M -45.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$67.1M -$16.7M -$4.5M -36.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$62.6M -$16.7M -$6.35M -61.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$56.2M -$19.6M -$10M -105% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$46.2M -$14.1M -$4.08M -40.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$42.1M -$12.2M -$4.59M -60% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$37.5M -$10.3M -$1.95M -23.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$35.6M -$9.57M -$1.57M -19.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$34M -$9.97M -$2.06M -26% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$32M -$7.65M -$742K -10.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-05
Q3 2016 -$31.2M -$8.39M -$2.06M -32.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$29.2M -$8M -$786K -10.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$28.4M -$7.92M -$592K -8.08% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$27.8M -$6.91M -$969K -16.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 -$26.8M -$6.33M -$344K -5.75% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$26.5M -$7.22M -$1.18M -19.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$25.3M -$7.32M -$387K -5.58% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$24.9M -$5.94M -$1.04M -21.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$23.9M -$5.98M -$836K -16.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 -$23M -$6.04M -$1.77M -41.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$21.3M -$6.94M -$3.58M -107% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$17.7M -$4.9M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 -$5.15M -$1.5M -41% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$4.27M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.36M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 -$3.65M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.